- Home
- DSGN vs FVR Comparison
DSGN vs FVR Comparison
Compare DSGN & FVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- FVR
- Stock Information
- Founded
- DSGN 2017
- FVR 2016
- Country
- DSGN United States
- FVR United States
- Employees
- DSGN N/A
- FVR N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- FVR
- Sector
- DSGN Health Care
- FVR
- Exchange
- DSGN Nasdaq
- FVR NYSE
- Market Cap
- DSGN 264.4M
- FVR 284.1M
- IPO Year
- DSGN 2021
- FVR 2024
- Fundamental
- Price
- DSGN $5.57
- FVR $18.73
- Analyst Decision
- DSGN Hold
- FVR Strong Buy
- Analyst Count
- DSGN 3
- FVR 5
- Target Price
- DSGN $7.00
- FVR $22.00
- AVG Volume (30 Days)
- DSGN 142.1K
- FVR 127.2K
- Earning Date
- DSGN 11-07-2024
- FVR 11-13-2024
- Dividend Yield
- DSGN N/A
- FVR N/A
- EPS Growth
- DSGN N/A
- FVR N/A
- EPS
- DSGN N/A
- FVR N/A
- Revenue
- DSGN N/A
- FVR $58,655,152.00
- Revenue This Year
- DSGN N/A
- FVR N/A
- Revenue Next Year
- DSGN N/A
- FVR $22.44
- P/E Ratio
- DSGN N/A
- FVR N/A
- Revenue Growth
- DSGN N/A
- FVR 1164.99
- 52 Week Low
- DSGN $2.13
- FVR $18.04
- 52 Week High
- DSGN $7.77
- FVR $19.76
- Technical
- Relative Strength Index (RSI)
- DSGN 47.80
- FVR N/A
- Support Level
- DSGN $5.32
- FVR N/A
- Resistance Level
- DSGN $7.77
- FVR N/A
- Average True Range (ATR)
- DSGN 0.58
- FVR 0.00
- MACD
- DSGN -0.09
- FVR 0.00
- Stochastic Oscillator
- DSGN 19.12
- FVR 0.00
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About FVR FRONTVIEW REIT INC
FrontView REIT Inc is an internally managed net-lease REIT that is experienced in acquiring, owning, and managing out parcel properties that are net-leased to a diversified group of tenants. Its tenants include service-oriented businesses, such as restaurants, cellular stores, financial institutions, automotive stores and dealers, medical and dental providers, pharmacies, convenience and gas stores, car washes, home improvement stores, grocery stores, professional services as well as general retail tenants.